KIMBERLY MARTIN: Open Payments
NPI 1861563728 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,907 in 121 payments from 26 companies in 2025. Trend: 2023 $1,692 · 2024 $1,987 · 2025 $1,907
Food & beverage: $1,907
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $372 |
| Novo Nordisk Inc | 15 | $265 |
| AstraZeneca Pharmaceuticals LP | 8 | $163 |
| GlaxoSmithKline, LLC. | 11 | $151 |
| Regeneron Healthcare Solutions, Inc. | 7 | $148 |
| Exact Sciences Corporation | 5 | $77 |
| PFIZER INC. | 4 | $75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $74 |
| Lilly USA, LLC | 3 | $56 |
| Phathom Pharmaceuticals, Inc. | 4 | $55 |
Products named: QULIPTA, DUPIXENT, AIRSUPRA, Wegovy, Ozempic, UBRELVY, SHINGRIX, Cologuard Collection Kit.
Industry payments across NC — which companies pay providers there.
